Company Filing History:
1 out of 1,309 
1 out of 3,539 
Years Active: 2009
Title: Padmalatha S Reddy: Innovator in Immune Cell Pathology Treatment
Introduction
Padmalatha S Reddy is a notable inventor based in Walpole, MA (US). She has made significant contributions to the field of immunology, particularly in the treatment of immune cell-associated pathologies. Her innovative work has led to the development of a patent that addresses critical health issues related to the immune system.
Latest Patents
Padmalatha S Reddy holds a patent for a method of treating or ameliorating an immune cell-associated pathology using GITR ligand antibodies. The patent describes a novel approach that provides isolated and purified polynucleotides and polypeptides related to a ligand for glucocorticoid-induced TNF receptor (GITR). This invention includes antibodies to the GITR ligand (GITRL) and outlines methods for diagnosing, prognosing, monitoring, and treating disorders arising from immune system dysregulation. These disorders include autoimmune diseases, inflammatory conditions, transplant rejection, cancers, and infectious diseases. The patent emphasizes the potential for novel therapeutics and therapeutic targets, as well as methods for screening and assessing test compounds for intervention and prevention of these disorders.
Career Highlights
Throughout her career, Padmalatha has worked with prominent organizations, including Wyeth and the National Institutes of Health, a component of the US Department of Health & Human Services. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Padmalatha has collaborated with notable colleagues, including Mary Collins and Ethan Shevach. These partnerships have enriched her research and expanded the impact of her innovations in immunology.
Conclusion
Padmalatha S Reddy's contributions to the field of immunology through her patent on GITR ligand antibodies exemplify her commitment to advancing medical science. Her work has the potential to significantly improve the treatment of various immune-related disorders.